Abstract:MicroRNA (miR)-221 plays an essential role in the epithelial-mesenchymal transition (EMT). High mobility group AT-hook 2 (HMGA2), is a key regulator of EMT. However, the role of miR‑221 in pulmonary fibrosis, and the association between miR‑221 and HMGA2 remain largely unknown. For this purpose, we examined the expression of miR‑221 and HMGA2 in human idiopathic pulmonary fibrosis (IPF) tissues and pulmonary cells, namely the adenocarcinoma A549 and human bronchial epithelium (HBE) cell lines, and found that the expression of miR‑221 was inhibited in both tissues and cells whereas high mRNA and protein expression of HMGA2 was observed. Additionally, transforming growth factor‑β1 (TGF‑β1) induced the EMT, characterized by the upregulated expression of the mesenchymal markers, namely N‑cadherin, vimentin, α‑smooth muscle actin, collagen I and collagen III, and the downregulated expression of the epithelial marker E-cadherin in A549 and HBE cells. We then performed transfection with miR‑221 mimics, and found that the expression of phosphorylated-Smad3 in miR‑221‑overexpressing cells was significantly downregulated, compared with that in the TGF‑β1-treated cells without transfection. Furthermore, the overexpression of miR‑221 decreased the expression of HMGA2, suppressed the EMT, and inhibited the proliferation of A549 and HBE cells. HMGA2 was directly targeted by miR‑221 which was confirmed by the dual-luciferase reporter gene assay. Finally, a mouse model of bleomycin (BLM)‑induced pulmonary fibrosis was used to confirm the effect of miR‑221 on EMT. Hematoxylin and eosin staining showed that BLM induced thicker alveolar walls and more collagen deposition, whereas miR‑221 treatment reduced lung fibrosis and the tissues exhibited thinner alveolar walls and normal lung alveoli. Furthermore, the EMT process was suppressed following miR‑221 injection. Taken together, these findings sugest that miR‑221 targets HMGA2 to inhibit BLM‑induced pulmonary fibrosis through the TGF‑β1/Smad3 signaling pathway.

Mir-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

MiR-34 B-5 P Knockdown Attenuates Bleomycin-Induced Pulmonary Fibrosis by Targeting Tissue Inhibitor of Metalloproteinase 3 ( TIMP 3 )

MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition.

Mir-301A Suppression Within Fibroblasts Limits the Progression of Fibrosis Through the TSC1/mTOR Pathway

MicroRNA-27a-3p is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation

Mir‑221 Targets HMGA2 to Inhibit Bleomycin‑induced Pulmonary Fibrosis by Regulating TGF‑β1/Smad3-induced EMT.

MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-/Smad ubiquitin regulatory factor-2 signalling

Peptide PD29 Treats Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β/smad Signaling Pathway.

Mir-34A Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.

Mir-192 Mediates TGF-beta/Smad3-driven Renal Fibrosis.

Regulation Mechanism of Microrna-29 on Transforming Growth Factor-Β1/smad3 Pathway in Pulmonary Fibrosis

Mir-146b Expression Is Upregulated In The Lung Of Pulmonary Fibrosis Mice

The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis

miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway

microRNA-142-3p inhibits apoptosis and inflammation induced by bleomycin through down-regulation of Cox-2 in MLE-12 cells

TMEM176B Prevents and alleviates bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor β-Smad signaling

SIS3, a Specific Inhibitor of Smad3, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.

Mmu-Microrna-92a-3p Attenuates Pulmonary Fibrosis by Modulating Cpeb4-mediated Smad2/3 Signaling Pathway

Baicalein Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats Through Inhibition of Mir-21.

P063 <break /> the Distribution and Efficacy of MiR-29 Mimicry As a Therapy for Pulmonary Fibrosis Induced by Bleomycin in Mice